Category Archives: Patent Eligible Subject Matter

Dr. Watson, Genomics and the Law

Posted on September 3, 2013 by Warren Woessner

Since the legal tsunami of court decisions affecting many aspects of life sciences – from patents on Round-UpTM Ready soybeans to “companion diagnostics” – has rolled back out to the sea of summer break, I have found time to reflect … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | 1 Comment

Patents at the Supreme Court: Update and Fallout

Posted on August 26, 2013 by Warren Woessner

Warren Woessner and Charles R. Macedo will speak on patentable subject matter post-Myriad, Prometheus and CLS in the upcoming AUTM Webinar on September 12.  Warren (Schwegman Lundberg) will present on the patentability of life sciences’ inventions such as diagnostics, drug … Continue reading →

Posted in Patent Eligible Subject Matter, Webinar | Tagged , , , , , , , | Leave a comment

Complimentary Webinar: Patenting DNA

Posted on July 25, 2013 by Warren Woessner

Join Robin Chadwick and me as we untangle the web of rulings in the upcoming webinar “Patenting DNA: Why DNA is Different and What to Do About It.”  The live CLE webinar will be presented on Wednesday, August 7th at … Continue reading →

Posted in Patent Eligible Subject Matter, Webinar | Tagged , , , , , , | Leave a comment

Bosch, Ultramercial, Commil, Fresenius: All-Star Break

Posted on July 23, 2013 by Warren Woessner

A guest post from Ron Schutz of Robins, Kaplan, Miller & Ciresi The Federal Circuit goes into the symbolic half-way point of summer leading the league with a series of homerun opinions. To keep the games back gap on updates … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , | Leave a comment